Skip to main content

Table 2 Whole blood concentrations of mefloquine on Day-0 (pre-treatment), days 7, 14, 21, 28, 35 and 42 of treatment in patients with sensitive response and recrudescence.

From: Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border

Day of treatment

Sensitive response

Recrudescence response

 

N

Mean (95%CI)* or Median (95% CI)**

N

Mean (95%CI)* or Median (95% CI)**

Day 0**

90

0 (0-1,714)

36

0 (0-92)

Day 1*

36

1,411 (1,216-1,605)

12

1,345 (1,067-1,624)

Day 7*

22

1,055 (806-1,304)

9

754 (541-968)

Day 14*

21

659 (426-893)

10

421 (181-660)

Day 21*

15

416 (258-575)

11

359 (230-488)

Day 28*

13

233 (158-307)

8

288 (146-329)

Day 35*

12

145 (96-195)

6

179 (41-317)

Day 42**

19

19 (5-163)

9

13 (0-49)